TITLE

Pharmacists as providers of HIV pre-exposure prophylaxis

AUTHOR(S)
Bruno, Christine; Saberi, Parya
PUB. DATE
December 2012
SOURCE
International Journal of Clinical Pharmacy;Dec2012, Vol. 34 Issue 6, p803
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as their ability to monitor and manage medication adverse effects and drug-drug interactions, clinical pharmacists are well-equipped to play a key role in effective PrEP utilization. Here we discuss reasons favoring the establishment of a protocol-based, pharmacist-run PrEP clinic.
ACCESSION #
83482024

 

Related Articles

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

  • Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel. Yeni, Patrick G.; Hammer, Scott M.; Hirsch, Martin S.; Saag, Michael S.; Schechter, Mauro; Carpenter, Charles C. J.; Fischl, Margaret A.; Gatell, Jose M.; Gazzard, Brian G.; Jacobsen, Donna M.; Katzenstein, David A.; Montaner, Julio S. G.; Richman, Douglas D.; Schooley, Robert T.; Thompson, Melanie A.; Vella, Stefano; Volberding, Paul A. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p251 

    Context Substantial changes in the field of human immunodeficiency virus (HIV) treatment have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral management of adults with established HIV infection. Objective To update recommendations for physicians who provide...

  • Where to Start?  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article states that the use of antiretroviral therapy for HIV patients still faces challenges, such as major adverse effects, difficulties of patients to comply with treatment regimen, and antiretroviral drug resistance. Patients are encouraged to visit www.hivinsite.org to obtain...

  • Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases. Oshikoya, Kazeem A.; Oreagba, Ibrahim A.; Ogunleye, Olayinka O.; Lawal, Saheed; Senbanjo, Idowu O. // Therapeutics & Clinical Risk Management;2013, Vol. 9, p215 

    Background: Drug-drug interactions are an important therapeutic challenge among human immunodeficiency virus-infected patients. Early recognition of drug-drug interactions is important, but conflicts do exist among drug compendia on drug interaction information. We aimed to evaluate the...

  • Has HAART failed? Soresen, Suellyn J.; Busti, Anthony J. // Drug Topics;5/16/2005, Vol. 149 Issue 10, DRUG TOPIC FOR THE... p8 

    Offers advice concerning the condition of an HIV-positive patient who is experiencing virologic failure due to antiretroviral drug interactions. Types of antiretroviral agents being administered to the patient; Increase in drug concentration and toxicity risk; Need for a potent and effective...

  • Antiretrovirals/fluoxetine/isoniazid.  // Reactions Weekly;9/19/2009, Issue 1270, p7 

    The article describes three cases of hyperactive delirium induced by antiretroviral therapy in three HIV-positive children with cerebral and/or cellebellar atrophy. It provides an overview of the antiretrovirals that the patients received. It relates that one of the patients developed serotonin...

  • On the Estimation of Expected Survival Time of AIDS Patients Undergoing Antiretroviral Therapy Using Censored Generalized Poisson Regression Model. GROVER, Gurprit; RAVI, Vajala // Turkiye Klinikleri Journal of Biostatistics;2014, Vol. 6 Issue 1, p24 

    Objective: The progression of HIV infection depends not only on the combination of drugs and adherence to the Anti Retroviral therapy (ART), but also on various other factors. The survival of an HIV patient depends on interaction of these factors with the therapy. Material and Methods: The...

  • HIV Infection: The Role of Primary Care. ROMANELLI, FRANK; MATHENY, SAMUEL C. // American Family Physician;11/1/2009, Vol. 80 Issue 9, p946 

    Human immunodeficiency virus infection was first documented in the United States in 1981. Since that time, significant strides have been made in the prevention and treatment of the condition. Screening is paramount in identifying early infection and is now a routine component of primary care....

  • Risk of cardiovascular disease in HIV-infected patients. Das, Satyajit // Journal of Antimicrobial Chemotherapy (JAC);Mar2010, Vol. 65 Issue 3, p386 

    The life expectancy of people living with HIV infection has improved dramatically since the use of highly active antiretroviral therapy (HAART). Now that patients with HIV infection are living longer, the focus of its treatment should shift to long-term management spanning decades. Diseases of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics